European Heart Journal · 2013 · 64 citations · 10 references
Public HealthBiostatisticsGeographyEpidemiologic MethodsEpidemiologyHealth GeographyClinical TrialsHeterogeneous Treatment EffectsSubgroup AnalysisTreatment Effect HeterogeneityTreatment EffectivenessTreatment EffectsClinical Trial ReportsComparative Clinical TrialsGeographic Heterogeneity AnalysisGeographical DisparitiesStatistical PowerStatistical Power EstimationStatistical TestingTreatment-effect Interaction
With the increasing globalization of clinical trials, the opportunity exists to explore potential geographic differences in treatment effect within any major trial. Such geographic differences may arise because of international differences in patient selection, medical practice, or evaluation of outcomes, and such international variations need better documentation in trial reports. Appropriate pre-defined statistical analyses, including statistical tests of interaction regarding geographic heterogeneity in treatment effect, are important. Geographic variations are a particularly tricky form of subgroup analysis: they lack statistical power, are at best hypothesis-generating and can generate more confusion than insight. Referring to key examples, e.g. the PLATO and MERIT-HF, we emphasize the need for caution in interpreting evidence of potential geographic inconsistencies in treatment effect. Although it is appropriate to explore any biological or practical reasons for apparent geographic anomalies in treatment effect, the play of chance is often the most plausible and wise interpretation.
10
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin, Richard C. Becker, Andrzej Budaj et al. · New England Journal of Medicine · 2009 · 7.1K citations · Full text
Subgroup analysis and other (mis)uses of baseline data in clinical trials
Susan F. Assmann, Stuart Pocock, Laura E. Enos et al. · The Lancet · 2000 · 1.2K citations